These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 24374295)

  • 1. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.
    Bajaj JS; Sikaroodi M; Shamsaddini A; Henseler Z; Santiago-Rodriguez T; Acharya C; Fagan A; Hylemon PB; Fuchs M; Gavis E; Ward T; Knights D; Gillevet PM
    Gut; 2021 Jun; 70(6):1162-1173. PubMed ID: 32998876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal dysbiosis in cirrhosis.
    Bajaj JS; Liu EJ; Kheradman R; Fagan A; Heuman DM; White M; Gavis EA; Hylemon P; Sikaroodi M; Gillevet PM
    Gut; 2018 Jun; 67(6):1146-1154. PubMed ID: 28578302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.
    Acharya C; Betrapally NS; Gillevet PM; Sterling RK; Akbarali H; White MB; Ganapathy D; Fagan A; Sikaroodi M; Bajaj JS
    Aliment Pharmacol Ther; 2017 Jan; 45(2):319-331. PubMed ID: 27868217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.
    Bajaj JS; Hylemon PB; Ridlon JM; Heuman DM; Daita K; White MB; Monteith P; Noble NA; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G675-85. PubMed ID: 22821944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of gut microbiome with cognition in hepatic encephalopathy.
    Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.
    Bajaj JS; Thacker LR; Fagan A; White MB; Gavis EA; Hylemon PB; Brown R; Acharya C; Heuman DM; Fuchs M; Dalmet S; Sikaroodi M; Gillevet PM
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico.
    Bajaj JS; Torre A; Rojas ML; Fagan A; Nandez IE; Gavis EA; De Leon Osorio O; White MB; Fuchs M; Sikaroodi M; Gillevet PM
    Liver Int; 2020 Jun; 40(6):1395-1407. PubMed ID: 32181561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
    Bajaj JS; Sterling RK; Betrapally NS; Nixon DE; Fuchs M; Daita K; Heuman DM; Sikaroodi M; Hylemon PB; White MB; Ganapathy D; Gillevet PM
    Aliment Pharmacol Ther; 2016 Sep; 44(6):638-43. PubMed ID: 27417456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Firmicutes/Bacteroidetes and Firmicutes/Proteobacteria ratios are associated with worse prognosis in a cohort of Latin American patients with cirrhosis.
    Mantovani A; Longo L; Thoen RU; Rampelotto PH; Salinas R; Guerreiro GTS; Álvares-da-Silva MR
    Clinics (Sao Paulo); 2024; 79():100471. PubMed ID: 39098143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
    Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Bajaj JS; Acharya C; Fagan A; White MB; Gavis E; Heuman DM; Hylemon PB; Fuchs M; Puri P; Schubert ML; Sanyal AJ; Sterling RK; Stravitz TR; Siddiqui MS; Luketic V; Lee H; Sikaroodi M; Gillevet PM
    Am J Gastroenterol; 2018 Aug; 113(8):1177-1186. PubMed ID: 29872220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
    Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
    J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.